Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/045906external-prioritypatent/WO2013009674A2/en
Application filed by Медсінс360filedCriticalМедсінс360
Publication of UA112315C2publicationCriticalpatent/UA112315C2/en
Infusion, Injection, And Reservoir Apparatuses
(AREA)
Abstract
Даний винахід стосується внутрішньоматкової системи (пристрою введення), яка містить внутрішньоматковий пристрій (пристрій IUD), пристрій введення або аплікатор для введення пристрою IUD в шийку пацієнтки, способів, пов'язаних із процедурою введення, і способів виготовлення пристрою введення.The present invention relates to an intrauterine system (input device) that contains an intrauterine device (IUD device), an input device or an applicator for inserting an IUD device into the patient's neck, methods associated with the procedure of injection, and methods of manufacturing the device input.
UAA201401306A2011-07-112012-09-07
INTERIOR SYSTEMS, IUD DEVICES, AND RELATED METHODS AND KITS
UA112315C2
(en)
Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy
APPLICATION OF 18-METHYL-15β, 16β-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES IN THE TREATMENT OF Menorrhagia, as well as intrauterine systems containing 18-Methyl-15β, 16β-Methylene-19-Methylene-19β, 16β-Methylene-19-containing 16-Methylene-19β, 16β-Methylene-19β 20-SPIROX-4-EN-3-ONE FOR THE TREATMENT OF Uterine Bleeding Disorders